IM Cannabis files Q3 2025 interim results on 6-K

IM Cannabis Corp. filed a Form 6-K as a foreign private issuer, providing investors with its unaudited interim condensed consolidated financial statements for the three and nine months ended September 30, 2025.

Rhea-AI Filing Summary

IM Cannabis Corp. filed a Form 6-K as a foreign private issuer, providing investors with its unaudited interim condensed consolidated financial statements for the three and nine months ended September 30, 2025. The filing also includes management’s discussion and analysis of financial condition and results of operations for the same periods, along with a press release titled “IM Cannabis Reports Third Quarter 2025 Financial Results.”

Most of this Form 6-K (excluding the “Management Commentary” section of the press release and two certification exhibits) is incorporated by reference into the company’s existing Form F-3 shelf registration statements, meaning this quarterly information now forms part of those registration documents going forward unless later superseded.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does IM Cannabis Corp. (IMCC) report in this Form 6-K?

The Form 6-K from IM Cannabis Corp. furnishes unaudited interim condensed consolidated financial statements and management’s discussion and analysis for the three and nine months ended September 30, 2025, plus a press release on its third quarter 2025 financial results.

Which periods are covered by IMCC’s interim financial statements in this filing?

The interim financial statements included in the Form 6-K cover the three and nine months ended September 30, 2025.

What additional documents are attached to IM Cannabis Corp.’s Form 6-K?

Attached to the Form 6-K are a news release dated November 13, 2025, the interim financial statements, the accompanying management’s discussion and analysis, and certifications of interim filings by the CFO and CEO.

How is this Form 6-K used in IMCC’s existing Form F-3 registration statements?

This Form 6-K, excluding the “Management Commentary” section of the press release and the two certification exhibits, is incorporated by reference into IM Cannabis Corp.’s Form F-3 registration statements, becoming part of those registration documents from the date of submission.

Which registration statements does IM Cannabis Corp. update with this Form 6-K?

The Form 6-K is incorporated by reference into IM Cannabis Corp.’s Form F-3 registration statements with file numbers 333-288346 and 333-289571.

Who signed the Form 6-K for IM Cannabis Corp.?

The Form 6-K was signed on behalf of IM Cannabis Corp. by Oren Shuster, who is the company’s Chief Executive Officer and Director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/13/2025 - 09:16 AM Learn about SEC filing dates

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025  (Report No. 2).

Commission File Number: 001-40065

IM Cannabis Corp.
(Exact Name of Registrant as Specified in Charter)

Kibbutz Glil Yam, Central District, Israel 4690500
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒      Form 40-F ☐

This Report of Foreign Private Issuer on Form 6-K consists of IM Cannabis Corp.’s (the “Company”): (i) Unaudited Interim Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2025, which are attached hereto as Exhibit 99.2; (ii) Management’s Discussion and Analysis of Financial Condition and Results of Operations for the three and nine months ended September 30, 2025, which is attached hereto as Exhibit 99.3; and (iii) a press release issued by the Company on September 13, 2025 titled “IM Cannabis Reports Third Quarter 2025 Financial Results”, which is attached hereto as Exhibit 99.1.

This Report of Foreign Private Issuer on Form 6-K, excluding the section titled “Management Commentary” of Exhibit 99.1, Exhibit 99.4 and Exhibit 99.5 hereto, is incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-288346 and File No. 333-289571) filed with the Securities and Exchange Commission to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

EXHIBIT INDEX

99.1 News Release dated November 13, 2025

99.2 Interim Consolidated Financial Statements for the three and nine months ended September 30, 2025

99.3 Management's Discussion and Analysis for the three and nine months ended September 30, 2025

99.4 Certification of Interim Filings by CFO dated November 13, 2025

99.5 Certification of Interim Filings by CEO dated November 13, 2025

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	IM CANNABIS CORP.
	(Registrant)
Date: November 13, 2025	By:	/s/ Oren Shuster
	Name:	Oren Shuster
	Title:	Chief Executive Officer and Director